equisetum giganteum butanolic extract

Equisetum giganteum butanolic extract is a research-grade natural product extract derived from the giant horsetail plant (*Equisetum giganteum* L.), which is endemic to Central and South America. The extract is characterized by a complex phytochemical profile containing glycosylated kaempferol derivatives, caffeic acid derivatives, flavonoids, and styrylpyrones. Preclinical academic research has demonstrated that the butanolic extract possesses significant antidiabetic, hypoglycemic, and hypolipidemic properties. In animal models of diabetes, such as alloxan-induced diabetic rabbits, administration of the extract has been shown to significantly reduce blood glucose, cholesterol, and triacylglycerol levels. Despite these promising pharmacological activities in research settings, there is currently no evidence of commercial pharmaceutical development, clinical trials in humans, or identified molecular targets for this specific extract.

Other names

giant horsetail butanolic extractEquisetum giganteum L. butanolic extract